Churg-Strauss syndrome [8]

Lancet

Volumn 361, Issue 9370, 2003, Pages 1746-

  Wardle, E N ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ENDOTHELIN RECEPTOR ANTAGONIST; HEPARIN DERIVATIVE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PENTOXIFYLLINE; PHOSPHODIESTERASE IV INHIBITOR; PICOTAMIDE; PROSTAGLANDIN E1; ROLIPRAM; THIAZOLIDINE DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

CELL PROLIFERATION; CHURG STRAUSS SYNDROME; DENDRITIC CELL; DRUG EFFICACY; ENDOTHELIUM CELL; EOSINOPHIL; GLOMERULONEPHRITIS; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR BLOCKING;

EID: 0037648970     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13349-1     Document Type: Letter

References (2)

1. Noth I., Strek M.E., Leff A.R. Churg-Strauss syndrome. Lancet. 361:2003;587-594.
2. Harizi H., Juzan M., Moreau J.F., Gualde N. Prostaglandins inhibit leukotriene B4 production from dendritic cells via an Il-10 dependent mechanism. J Immunol. 170:2003;139-146.